The formation of myofibroblasts in valve interstitial cell (VIC) populations contributes to fibrotic valvular disease. We examined myofibroblast differentiation in VICs from porcine aortic valves.
Introduction
Valvular heart disease is responsible for >19,800 deaths/year, is a contributing factor to over 42,500 deaths and accounts for ~95,000 hospital discharges and ~50,000 valve replacement surgeries each year in the USA alone (49) . Of the four heart valves, the aortic valve is most commonly affected by disease. Aortic valve sclerosis affects 20-30% of the population 65-74 years of age (36, 45) and aortic stenosis affects 2-4% of individuals >84 years (27, 36, 45) . In diseased states, the structural integrity of the aortic valve is disrupted by the combined effects of increased cellularity, lipid accumulation, and the deposition of a disorganized extracellular matrix (ECM) (35, 56) . These changes lead to imperfect coaptation, stiffening of the leaflets and disturbed hemodynamic flow.
The phenotype and metabolism of valve interstitial cells (VICs) are critical determinants of valve morphology and function in health and disease (26, 40) . VICs are the most abundant cells in valves and are responsible for synthesizing and remodeling the ECM (40) that ultimately determines the mechanical properties and function of the valve. During development, VICs may arise in part from endocardial endothelial cells that have undergone epithelial-to-mesenchymal transformation (15, 30) . Transitions in early embryonic atrioventricular valvular function are related to changes of endocardial cushion biomechanics that in turn are dependent on tissue composition(7). In normal valves VICs exhibit the morphological appearance of fibroblasts, but when activated by disease, excessive mechanical forces or TGF-1 , VICs can mediate alterations of ECM biomechanics that can alter valve function (37, 40, 53) .
VIC populations are not well defined in adult mammals but likely comprise a heterogeneous population consisting of fibroblasts, myofibroblasts and smooth muscle cells (3, 12, 32, 33, 47) . In healthy valves, the majority of interstitial cells are probably quiescent fibroblasts; only a small percentage (2.5%) are considered to be myofibroblasts (8, 37) . If 4 present at all, myofibroblasts appear to be restricted to the ventricular side of the leaflet interstitium (39) or are found in clusters in the spongiosa (5) . In diseased valves, the appearance and localization of myofibroblasts are correlated with ECM disorganization, increased levels of matrix metalloproteinase expression, the formation of degenerative lesions and fibrosis (34, 35, 38, 44) . Activation of valve myofibroblasts by pro-fibrotic cytokines like TGF-may play an important role in the pathogenesis of valve stenosis and sclerosis (53) .
In cells cultured from valves, some reports estimate that a substantial percentage of myofibroblasts comprise the VIC population (25) while others have found few myofibroblasts in fresh isolated ovine aortic and porcine pulmonary VICs (39) . The reported prevalence range of myofibroblasts is wide (7-100%) with a mean of ~50% (47) , similar to that of other studies (53) (48) . In one report of continuously cultured VICs, the expression of SMA, a myofibroblast marker, was initially high and then decreased with higher passage number. In contrast, another report described a relatively constant expression of SMA, regardless of passage number (47) , while others have found increased percentages of myofibroblasts at higher passage number (57) .
Currently, the origins and the biological factors that regulate differentiation of myofibroblasts from VICs are not defined. We used a pig aortic valve model and analysis of side population cells by flow cytometry to examine the growth and differentiation of myofibroblasts from VICs. We employed isotope coded affinity tag methods to screen for proteins that are differentially expressed in myofibroblast differentiation of cultured VICs. The data show that: 1) some myofibroblasts from VICs originate from a small precursor population that is enriched in side population cells; 2) myofibroblast differentiation of VICs in vitro is regulated by the stiffness of the extracellular matrix; 3) the actin severing protein cofilin is expressed during myofibroblast differentiation of VICs and is required for expression of SMA in stress fibers and for collagen gel contraction. 6 ability of cells to contract collagen gels using the stress-relaxed gel contraction assay described earlier(23). Passage numbers were assigned consecutively after the initial plating.
Isotope Coded Affinity Tags (ICAT)
The production and analysis of ICAT-labeled peptides were performed according to the manufacturer's protocols (Applied Biosystems, Foster City, CA). Myofibroblast-differentiated (day 7, primary cultures) and undifferentiated cultures (day 3, primary cultures) were lysed in 0.5% SDS, 0.25M tris-hydroxymethylaminomethane (Tris), and protein quantification was performed using the Pierce BCA protein assay. ICAT-labeled samples were prepared with cleavable ICAT reagent, which reacts specifically with cysteine sulphydryls and leaves an attached biotin group. To equal amounts of myofibroblast and undifferentiated culture protein samples (100 µg each), in denaturing buffer containing 50 mM Tris and 0.1% SDS (pH 8.5), Tris[2-carboxyethyl]phosphine hydrochloride was added to enable disulfide reduction for 15 min at 37°C, followed by addition of the appropriate ICAT reagent in acetonitrile at 37°C. Light and heavy labeled samples were combined prior to digestion with porcine trypsin for 18 h at 37°C in ammonium bicarbonate buffer (pH 8.5). Excess reagents were removed with a cation exchange cartridge (Applied Biosystems) and biotin-labeled ICAT peptides were isolated by avidin affinity column chromatography. The biotin group was cleaved from eluted peptides using trifluoroacetic acid. Samples were lyophilized and taken up in acetonitrile and trifluoroacetic acid for analysis by nanoHPLC (Agilent HPLC 100 series) and an Applied Biosystems/MDS Sciex API QSTAR XL Pulsar mass spectrometer. The data were analyzed with ProICAT SP2 (Applied Biosystems, version 1.1). The tandem MS data were submitted for database searching to Mascot and the non-redundant NCBI protein database was used. For quantifying the relative abundance of a protein, the peak height of the monoisotopic peak of the light ICAT-labeled peptide was divided by the peak height of the monoisotopic peak of the heavy labeled form of the peptide. 
Immunoblotting
The protein concentrations of cell lysates were determined by Pierce BCA protein assay. Equal amounts of protein were loaded on to SDS-polyacrylamide gels (10% or 12% acrylamide), resolved by electrophoresis, transferred to nitrocellulose membranes, immunoblotted for SMA, GAPDH or cofilin (Cell Signaling), and blot density was quantified as described (54) .
Short Interfering RNA
Specific inhibition of cofilin was conducted with Silencer siRNAs (Ambion) with the following human sequences which were used simultaneously: CCAGUAAGGGACCUUCGAUtt, GGGAUCAAGCAUGAAUUGCtt, and GGAGAGCAAGAAGGAGGAUtt. Day 1 primary culture cells were transfected with 200 nM of cofilin siRNA or a GFP negative control siRNA (Ambion) using oligofectamine (InVitrogen) for 5h. After transfection, cells were washed with PBS and incubated in DME medium containing 10% serum, allowed to proliferate for 48h. Cells were washed in PBS, lysed with Laemmli buffer and immunoblotted to assess the efficacy of the siRNA knockdown. In a subset of cells, after 48 h, transfections were repeated with cofilin siRNA or a GFP negative control siRNA (both 200 nM). Cells were allowed to proliferate for 9 48h and the efficacy of siRNA knockdown was assessed. Day 1 primary culture cells incubated in DME medium containing 10% serum served as a positive control for the duration of the transfection experiment.
Tensile Force Application
Exogenous tensile forces were applied in vitro as described previously (55) to examine inducibility of SMA in VICs. Briefly, magnetite beads (400 mg; Sigma) were incubated for 30 min with 1 ml of an acidic bovine collagen solution (>95% type I collagen; 3 mg/ml) at 37°C and neutralized to pH 7.4 with NaOH. Under these conditions, collagen polymerizes and forms fibrils around the beads within 30 min. The beads were sonicated to eliminate clumps and were then dispersed. Prior to incubation with cells, beads were rinsed in PBS, washed, re-suspended in Ca 2+ -free buffer, and added to attached cells in complete medium. Cells were washed three times to remove unbound beads prior to exposure to force. A ceramic permanent magnet was used to apply perpendicular forces to beads attached to the dorsal surface of cells. For all experiments, the pole face was parallel with and 2 cm from the surface of the cell culture dish. As the surface area of the magnet was larger than the culture dishes, and as the bead covering was relatively uniform for all cells, the forces applied to cells across the width of the culture dish were relatively uniform (21). Constant forces (0.65 pN/µm 2 projected cell area) were used for all experiments.
Statistical Analyses
For quantitative data, means and standard errors were computed. When appropriate, comparisons between groups were evaluated by Student's t-test or with ANOVA. Post hoc testing was carried out with Tukey's test. Statistical significance was set at p<0.05. For all analyses, data from n 3 independent experiments were used. In each experiment 3 replicates were used. For ICAT, discriminant analysis was used. Statistical significance for positive protein identification was set at >99% and with acceptable Prot. Scores of 2.0 considered reliable. from 10 different isolates) that were usually spatially clustered in the culture dishes, suggesting clonal expansion, and that also stained for collagen type I (98.2±2.2% of SMA-stained cells were also positive for collagen type 1; Fig. 1D ). The cells that were not stained for SMA were not usually stained for collagen type 1 (85±5% of SMA-negative cells were unstained for collagen type 1). If primary cultures were grown for >6 days, SMA positive cells were also commonly observed but not if cultured for <3 days (Fig. 1E ).
Results
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We examined induction of SMA in cultured VICs in more detail. Freshly isolated VICs were plated and split 4:1 at passaging. The population doubling time of the cultures up to passage 5 was ~30 hours. The % of SMA positive cells at the end of each passage ranged between 7-21%, depending on passage number. At each passage, an aliquot was immunoblotted for SMA and GAPDH. For all isolates (N=25), there was a strong increase of SMA expression between cells at early and late stages of primary culture (the fresh isolate). In some instances, there was no detectable SMA up to day 3 in first passage cultures ( Fig. 2A) . Analysis of a larger number cultures by quantification of the ratio of immunoblot densities of SMA normalized to GAPDH
showed that SMA increased 4-fold between isolation and day 7 of culture (n=10 cultures). When SMA was quantified over different passages of culture, there was somewhat more abundant SMA at passage 1 which often fluctuated up to passage 8, but there were no significant differences of SMA content over passaging ( To determine if SMA expression in porcine VICs could be enhanced by TGF-as has been reported earlier (53), passage 1, day 2 cells on rigid collagen substrates were transferred to serum-reduced medium (0.5% serum overnight) and treated with TGF-1 (10 ng/ml for 2 days) or with vehicle (for 2 days). There was a slight (~20% by densitometry) reduction of SMA content in TGF-1 -treated compared to vehicle-treated cultures (Fig. 3A) . Similar results were found in cells plated on tissue culture plastic (data not shown). We also examined SMA expression in passage 12 cells, but TGF-did not increase SMA expression in these cells either. This lack of effect of TGF-was not due to ineffective reagents as SMA was strongly increased by TGF-in human cardiac fibroblasts that were used as a positive control (2) . Further, this lack of effect was also not due to the cells already being fully differentiated as we purposefully used cells at the beginning of the experiment that did not express SMA.
Previous data have shown that in gingival fibroblasts, TGF--induced SMA expression is dependent on the compliance of the collagen substrate, which in turn regulates the ability of cells to generate endogenous forces (2) . In this experimental approach, cell-generated forces are developed in cultures on rigid but not compliant collagen gels. We plated primary culture cells and allowed them to proliferate for 7 days on rigid or soft collagen substrates as previously characterized (2) and stained cells with FITC-phalloidin. While cells on rigid substrates formed well-defined actin stress fibers, cells on soft substrates did not (Fig. 3B ), indicating that they generated low levels of intracellular tension. When cells under these same conditions were 14 immunostained for SMA, only cells plated on rigid collagen gels expressed SMA (Fig. 3C,D) .
We next determined if treatment with TGF-could overcome this reliance on substrate rigidity for SMA expression. After TGF-(10 µg/ml) treatment, primary culture cells at day 7 grown on soft collagen did not express SMA (Fig. 3E ) while cells on rigid collagen substrates showed abundant SMA staining (Fig. 3F) . Consistent with the immunoblotting data above, TGFtreatment did not enhance staining for SMA (compare Fig. 3D, F panels) . These data indicated that myofibroblast differentiation of VICs in vitro is regulated by the stiffness of the ECM and that cell-generated tensile forces may be particularly important for regulating this process.
As exogenous tensile force can rapidly enhance SMA expression in fibroblasts (54), we determined if tensile forces, without simultaneous TGF-treatment, could increase SMA expression in VICs. Passage 2, day 3 cells were incubated with collagen-coated magnetite beads and subjected to vertically directed tensile forces (0.5 pN/ µm 2 of cell surface (20)) for 8 hours.
Under these experimental conditions, when SMA content was adjusted for cell protein by blotting for GAPDH and analyzed by densitometry, SMA was significantly increased ( Fig. 3G ; SMA:
GAPDH blot density ratios-no force=1.9±0.3; force=3.2±0.4; p<0.05). Therefore both exogenous and endogenous (cell-generated) forces can enhance SMA expression.
Since myofibroblast differentiation, as assessed by pronounced increases of SMA expression, consistently occurred in late stage primary cultures or passage 1-2 cultures plated on rigid substrates, we screened for differential protein expression by isotope-coded affinity tags (ICAT) in cultures from these same conditions. Lysates (100 µg) were pooled from primary cultures at day 3 or day 7 and immunoblotted for SMA. First, we established culture conditions where there was very low SMA expression in the day 3 cultures but abundant SMA in day 7 cultures (Fig. 4A ). These culture conditions promoted the formation of cells from VICs with the phenotypes of pre-myofibroblasts and myofibroblasts, respectively. The lysates from these same 15 cultures were denatured, reduced, labeled with either light or heavy (+9 Da) ICAT biotin-coupled reagents, combined, digested with trypsin, fractionated by cationic exchange, purified with avidin columns, cleaved and analyzed by HPLC and tandem mass spectrometry. In two separate analyses, using discriminant analysis (with positive protein identification set at >99%) and Prot.
Scores of 2.0 or greater, 6 and 7 different novel proteins (not including SMA) from the two analyses were identified as being differentially expressed under the two experimental different conditions. From the 88 peptides that were identified with >99% certainty, 9 different proteins were predicted to be differentially expressed in the two analyses (4 proteins were common to the two analyses). The proteins that were identified in the first analysis included fetuin, enolase 1, cyclophilin A, vimentin and cofilin (with 2 high probability peptides identified). In the second analysis, enolase 1, cyclophilin A, non-muscle myosin II-A, vimentin and cofilin (with 4 high probability peptides identified) were found. Of these proteins, since cofilin was found in both analyses and was of particular interest because of its role in mediating the formation of stable actin filaments and stress fibers (1), we investigated it in more detail.
To determine if the ICAT analyses were consistent with independent immunochemical examination, we immunoblotted VIC primary cultures for cofilin under conditions that would prevent or enable myofibroblast differentiation, respectively. In three separate cultures each, cofilin expression was increased by >3-fold in myofibroblast differentiated cultures (7 days growth) compared to pre-myofibroblast primary cultures ( Fig. 4B; 3 days growth) . Next, we determined if knockdown of cofilin by siRNA was feasible in VIC cultures. Cofilin knockdown (2 days treatment) in primary cultures reduced cofilin content by >80% compared to irrelevant GFP siRNA but only slightly reduced the expression of SMA as measured by immunoblotting (Fig. 4C) . Notably however, cofilin knockdown substantially reduced the ability of myofibroblasts derived from VICs to form brightly staining SMA-containing stress fibers ( Fig. 16 4D1,2), which are thought to be important in cell contractility and are a hallmark of myofibroblast differentiation (50) . Cofilin knockdown also reduced by 2-fold, compared to irrelevant siRNA controls, the contraction of stress-relaxed collagen gels ( Fig. 4E; p<0 .001 at all sample times). The agreement between the data of stress fiber formation and stress-relaxed collagen gel contraction indicate that in VICs, cofilin plays an important role in mediating cell contraction, further underlining its utility as a marker of myofibroblast, which are contractile cells.
As cofilin is associated with the formation of stress fibers in certain cell types(1) and phosphorylation of cofilin stabilizes actin filaments (10), we measured the ratios of phosphocofilin to cofilin in cells from pre-myofibroblast and myofibroblast differentiated cultures. Cells were serum-starved overnight and then serum was added one hour before preparation of cell lysates for immunoblotting (Fig. 4F) . We anticipated that the serum stimulation would activate cofilin. As before, we found much more cofilin in the myofibroblasts than the pre-myofibroblast, consistent with the notion that cofilin is a myofibroblast marker. After adjustment for the much reduced cofilin in pre-myofibroblasts, we found that there was >2.5-fold greater phospho-cofilin in myofibroblasts than pre-myofibroblasts (p-cofilin:cofilin immunoblot densities-premyofibroblasts=0.97±0.2; myofibroblasts-2.6±0.2; p<0.01).
In porcine valves immunostained for cofilin, normal valves displayed low intensity staining throughout the valve interstitium while diseased valves exhibited strong staining for cofilin of cells in focal clusters that co-localized with SMA ( Fig. 4G) , consistent with the notion that myofibroblasts are clonally distributed in diseased valves.
Discussion
The principal findings of this study are that: 1) myofibroblasts in VIC populations arise by clonal expansion, in part from a relatively small number of progenitor cells; 2) the mechanical stiffness of the extracellular matrix and exogenous tensile force can regulate myofibroblast differentiation of VICs in culture; and 3) cofilin is a marker for myofibroblast differentiation in VICs and plays an important role in the ability of VICs to form stress fibers and to contract collagen gels. These data point to the possible existence of rare stem cells in VICs both in vivo and in vitro that contribute to the formation of myofibroblasts and that may contribute to the development of sclerotic valves. Further, cell-generated forces are evidently a critical determinant of myofibroblast differentiation since rigid substrates are required for SMA expression in vitro, which may provide an in vitro model for the stiffening of the sclerotic valve. Finally, cofilin appears to be a marker of, and may be required for, myofibroblast differentiation. This finding has important implications since matrix remodeling by VIC cells is reliant on the development of cell-generated forces, which likely involve cofilin.
Myofibroblasts have been found in cardiac valves (33, 37) and are likely important in the pathogenesis of valve sclerosis and stenosis (40) , but the factors that regulate their formation are not defined. Myofibroblasts were first described over 30 years ago in granulation tissue (19) and were named because they exhibited characteristics of both fibroblasts and smooth muscle cells We found that SMA expression in cultured VICs was markedly regulated by matrix compliance, as has been reported earlier for gingival fibroblasts (2) and that exogenous tensile forces could increase SMA expression, as has been reported earlier for Rat-2 fibroblasts(55). The stiffening of valves that occurs in disease may be mediated by VICs responses to local tissue stress by altering cellular stiffness (possibly by increasing SMA content) and by increased synthesis of collagen fibrils(31). Our finding that independent of the matrix ligand itself (i.e. collagen), the stiffness of the matrix was a determining factor for VICs differentiating into myofibroblasts. These in vitro data point to an important role for the increased stiffness of 20 sclerotic valves and local deforming forces as contributing factors to subsequent myofibroblast formation and further inhibition of valve function.
In addition to mechanical force, TGF-1 is one of the primary direct inducers of fibroblast-to-myofibroblast differentiation (13, 42, 51) and exhibits a strong, dose-dependent induction of SMA (51, 53) . In contrast to a previous report (53) , our data showed no significant enhancement of SMA expression in cultured VICs, even when the cells were grown on rigid substrates, a condition that is necessary for myofibroblast differentiation (2) and when cells with very low SMA content were treated. Conceivably the VICs that were examined here expressed some form of TGF-resistance, possibly because of reduction of TGF-receptors as has been observed earlier in fibroblasts that express less SMA in response to matrix effects (24).
We found that cofilin is co-expressed with SMA in the culture-induced conversion of premyofibroblasts to myofibroblasts. The observation that cofilin is a potential marker of myofibroblast differentiation in VICs is consistent with earlier findings in fibroblasts (4, 9, 29) and supports the notion that stress fiber assembly and the formation of stable actin filament arrays in cells is mediated by cofilin (1). While SMA expression was not significantly altered after siRNA cofilin knockdown, the incorporation of SMA into stress fibers of cultured myofibroblasts was almost completely absent. As the formation of SMA-containing stress fibers is a defining criterion for myofibroblasts (14) , the knockdown of an actin binding protein such as cofilin that is apparently required for stress fiber assembly indicates that cofilin may be both a marker and a required protein for myofibroblast differentiation in diseased heart valves. Further, cofilin knockdown strongly inhibited the contraction of stress-relaxed collagen gels. These data indicate that cofilin is not just a marker of myofibroblast differentiation but may contribute to the determination of the differentiated state. Further, as phosphorylation of cofilin blocks actin severing and promotes actin filament stabilization (46), our finding that myofibroblasts have a 21 much greater ratio of phosphorylated cofilin to cofilin than do pre-myofibroblasts, indicates that the expression level and phosphorylation status of cofilin in VICs has important effects on stress fiber formation and presumably, collagen contraction.
In summary, our data point to the presence of rare progenitor/stem cells in VIC populations that are clonally distributed, both in vivo and in vitro. These cells contribute to the formation of myofibroblasts and therefore may have an impact on the stiffening of sclerotic valves. Our data also show that cofilin is a novel myofibroblast marker and functionally contributes to the development of cell-generated forces, which are critical for matrix remodeling by VIC cells. 
